Evaluating the efficacy of low-molecular-weight heparin in managing umbilical artery thrombosis during pregnancy: does it offer therapeutic benefits?
Our study suggests that expectant therapy may offer substantial benefits compared to experimental therapy involving the administration of LMWH.
Authors
- Yicheng Lu (ORCID: https://orcid.org/0009-0003-7404-7733)
- Peng Zhao (ORCID: https://orcid.org/0000-0003-0899-7303)
- Xiaofu Yang (ORCID: https://orcid.org/0000-0002-5422-8946)
- Chong Chen (ORCID: https://orcid.org/0000-0003-2940-2030)
- Lidan Zhang (ORCID: https://orcid.org/0000-0002-2169-6823)
- Sitong Liu (ORCID: https://orcid.org/0000-0002-0709-2935)
Institutions
- Women's Hospital, School of Medicine, Zhejiang University (CN)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2025-03-24
- DOI
- https://doi.org/10.3389/fmed.2025.1540685
- Citations
- 1
- Primary Topic
- Pregnancy and preeclampsia studies
- Type
- article
- Field-Weighted Citation Impact
- 2.06